MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Fingerprint Dive into the research topics of 'MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences